The role of probiotic in the treatment of diarrhea in children

Renata Pharmaceutical Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•i. Children age: from 1 month to 12 years
•ii. Patients with both sexes
•iii. Patients who will suffer from dehydrating acute watery diarrhea of less than 14 days
•iv. Patients with clinical signs and symptoms of â??someâ?? dehydration
•(Thirst or eagerness to drink, sunken eyes, dry mouth and tongue and loss of skin elasticity (WHO 2006)
•v. Children who will have capacity to take oral medications

•i.Patients who will have a history of an episode of diarrhea within one month of the present illness to exclude recurrent and persistent diarrhea
•ii.Patients who will have severe dehydration
•iii.Patients will have severe malnutrition as defined by Waterlow classification
•iv.Patients who will have diarrhea associated with another systemic illness (e.g. septicemia, pneumonia, urinary tract infection, and otitis media
•v. Patients who will have known hypersensitivity reaction to probiotics
•vi. Patients who will receive any antibiotic therapy within 1 month prior to inclusion in study

发起方

Renata Pharmaceutical Ltd